LFCR FY 2025 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$129M+0.5% YoY

Gross Profit

$40M31.3% margin

Operating Income

-$17M-13.4% margin

Net Income

-$39M-30.0% margin

EPS (Diluted)

$-1.27

Cash Flow

Operating Cash Flow

-$206,000

Free Cash Flow

-$14M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$239M

Total Liabilities

$238M

Stockholders' Equity

$1M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$129M	$128M	+0.5%
Gross Profit	$40M	$42M	-3.7%
Operating Income	-$17M	-$9M	-95.0%
Net Income	-$39M	$12M	-422.3%